Vernalis loses CEO and US business in shake-up
Peter Fellner, the executive chairman of Vernalis, has orchestrated a huge restructuring at the loss-making biotechnology company that will see it retreat from America, cut more than half of its workforce, and result in the departure of its chief executive.
Mr Fellner, the former head of Celltech and one of the most respected figures in the UK biotech industry, said yesterday that he plans to return the company once known as British Biotech to its roots as a research and development-focused company with operations centred in Cambridge. The aggressive programme unveiled yesterday will undo most of what was done by chief executive Simon Sturge, who tried to reshape the company through a series of acquisitions into a speciality pharmaceutical company focused on America.
Mr Sturge will leave next month. Vernalis's cash-burn will be reduced from about £20m per year to £9m through the cutting of its 210-strong workforce to 90, with at least half the redundancies coming to the US salesforce.
Vernalis also reached a crucial settlement on a $56m (£28m) loan that it had taken out from partner Endo Pharmaceuticals. Under the deal, the company agreed to repay $7m to Endo and give up its rights to US royalties from migraine medication Frova. Under the original financing terms, Vernalis would have had to pay back the loan in its entirety by August next year, a worry that has weighed heavily on the cash-poor company.
Mr Fellner said he was in talks with three bidders interested in buying its Parkinson's treatment Ap-okyn. Doing so would complete the company's exit from America.
- 1 Man who was struck and killed by lightning in Brecon Beacons 'was carrying a selfie stick'
- 2 Lisa Randolph-Gant: Queen Elsa cake maker says she will carry on baking and will not let people 'break her spirit'
- 3 Tube strike: This pedestrian-friendly map tells you time it takes to walk between stations
- 4 Pamplona Running of the Bulls 2015: Three men gored and 10 hospitalised on first day of festival
- 5 Sarah Jessica Parker explains why she is not a feminist: 'It's not just about women now'
Man who was struck and killed by lightning in Brecon Beacons 'was carrying a selfie stick'
Greece debt crisis: Greek future in the euro slips into deeper uncertainty as Alexis Tsipras arrives at emergency talks without written plan
Man soars over Calgary after tying 110 balloons filled with helium to his lawn chair for PR stunt, gets arrested for mischief
Tube strike: This pedestrian-friendly map tells you time it takes to walk between stations
Pamplona Running of the Bulls 2015: Three men gored and 10 hospitalised on first day of festival
More Britons believe that multiculturalism makes the country worse - not better, says poll
Osborne to cap family benefits at £23,000 – announced ahead of his post-election Budget
Nathan Collier: Montana man inspired by same-sex marriage ruling requests right to wed two wives
Sickness and disability benefits could be reduced by £30 a week as part of £12bn welfare cuts
Greece debt crisis: Angela Merkel and Francois Hollande issue Athens with 24-hour ultimatum to avoid crashing out of the euro
Greece crisis: Referendum exposes a gaping hole at the heart of the European Union – its lack of genuine legitimacy
iJobs Money & Business
£40000 - £95000 per annum: Recruitment Genius: This is an exciting opportunity...
competitive: SThree: Are you passionate about sales?Do you have a keen interes...
£17000 - £30000 per annum: Recruitment Genius: This is an exciting opportunity...
£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...